Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

NEOGAP Therapeutics AB

Closing information (x1000 EUR)

Closing information 2024/12 2023/12 2022/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 0 More Arrow 22 More Arrow 115
Earnings before taxes -498 Less Arrow -1,031 Less Arrow -5,440
EBITDA -517 More Arrow -492 More Arrow -231
Total assets 9,188 More Arrow 11,009 Less Arrow 5,713
Current assets 1,942 More Arrow 5,056 Less Arrow 2,251
Current liabilities 803 More Arrow 1,812 Less Arrow 368
Equity capital 3,728 More Arrow 4,375 Less Arrow 537
- share capital 12 Equal arrow 12 Less Arrow 7
Employees (average) 17 Less Arrow 14 Equal arrow 14

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 40.6% Less Arrow 39.7% Less Arrow 9.4%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -5.4% Less Arrow -9.2% Less Arrow -93.2%
Current ratio 241.8% More Arrow 279.0% More Arrow 611.7%
Return on equity (ROE) -13.4% Less Arrow -23.6% Less Arrow -1013.0%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 3 Less Arrow 0 More Arrow 1
Chg. No. of employees % 21% Less Arrow 0% More Arrow 8%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.